CCCC|C4 Therapeutics Inc|Price:3.580|Chg%:+0.180
This article provides a comprehensive stock analysis of C4 Therapeutics Inc (CCCC), highlighting its healthy fundamentals and significant growth potential within the Biotechnology & Medical Research industry. The company is currently fairly valued, with very high institutional ownership, and analysts have issued "Buy" ratings …